Early Kasai surgery with stem cells for biliary atresia
Part of Digestive system, Genetic & congenital clinical trials.
This study tests whether giving umbilical cord stem cells during early Kasai surgery (a procedure to help drain bile) improves outcomes for infants with biliary atresia. It may help your baby's liver function and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be diagnosed with biliary atresia (a condition where bile ducts are blocked).
- Your baby must have had Kasai surgery (a procedure to restore bile flow) before 90 days of age.
- Your baby must not have severe malnutrition (significant weight or growth problems).
- Your baby must not have other major birth defects besides biliary atresia.
- Your baby must not have positive tumor markers (signs of cancer).
- Parents or guardians must agree to the study and follow all procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
This study maps how biliary atresia (a childhood blockage/problem with bile flow from the liver) progresses and changes in the body around the time of a liver transplant. It may help doctors better understand the disease and improve future care.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.